Adell Harriman & Carpenter Inc. raised its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 20.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,711 shares of the healthcare conglomerate’s stock after purchasing an additional 3,050 shares during the quarter. Adell Harriman & Carpenter Inc.’s holdings in UnitedHealth Group were worth $3,469,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $121,000. Finally, Acrospire Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after buying an additional 400 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.
UnitedHealth Group Inc (UNH) opened at $228.64 on Friday. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a market capitalization of $221,060.00, a P/E ratio of 25.98, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the prior year, the firm earned $2.17 earnings per share. The business’s revenue was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
A number of research firms recently weighed in on UNH. Cantor Fitzgerald upped their price target on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $245.00 price target (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Credit Suisse Group began coverage on UnitedHealth Group in a report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price target for the company. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Finally, Royal Bank of Canada upped their price target on UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $229.54.
In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last three months. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.